Unique Access Medical now offers an innovative treatment that combines an epidural stimulation device, mesenchymal stem cells treatment and rehab, all in one unique treatment. Key to this treatment programme is the epidural stimulation device which is responsible for sending electrical currents to the lower part of the spinal cord.
The epidural stimulation, combined with extensive physiotherapy, mapping and programming to train the body how to control movement using the device, and powerful and effective stem cell therapy, guarantee the best possible treatment outcome.
Made world-famous in 2014 by the Christopher & Dana Reeve Foundation, the treatment involves implanting an epidural spinal cord stimulator in a relatively straightforward surgical procedure.
The device, which is proven safe, locally activates nerve circuits in the spinal cord by imitating brain nerve signals.
Our protocol combines device implantation with extensive physiotherapy, mapping and programming to train the body how to control movement using the device, and powerful and effective stem cell therapy.
The combined experience in helping patients achieve the best possible results is as unique as the treatment programme itself.
Unique Access Medical offers the most comprehensive SCI treatment programme in the world by combining the epidural stimulation device, stem cell regenerative therapy, and functional rehabilitation.
The rehabilitation programme is central to the treatment and lasts 40 days, takes place at a world-class hospital, and has the following goals:
The epidural stimulation device is used to reconnect the brain and spinal cord.
The implanted device needs extensive calibration to discover the unique pattern of the patient’s physiological injury and then go on to help the patients gain control of their movements.
This effective combination of the most advanced medical technologies, with systematic physical and occupational therapies and high quality stem cells, has helped previously treated patients achieve significant advances with their paralysis.
Mechanical trauma to the spinal cord often results in irreversible damage. When axons in the central nervous system are injured, they show a very poor regenerative response and complete or partial paralysis has been the ultimate fate.
Mesenchymal stem cells (MSCs) have emerged as the leading stem cell type due to their proven safety, ability to regulate the immune system’s reaction towards the injury, and to differentiate in different cell types including neurons and astrocytes. They have been used in the clinical treatment of SCI patients since 2005.
Cell therapy can assist in regrowth of brain cells and improved neurological function by stimulating and repairing nerve tissue. The mesenchymal stem cells migrate and implement regeneration as well as activate the surrounding cells to catalyse rapid healing via angiogenesis, neurogenesis, and synapto-genesis to improve brain function. It can also repair the myelin sheath to promote nerve integrality and achieve normal conduction activity.
Improvements seen in patients after implantation: